Anavex2-73 oral liquid    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
156レット症候群1

156. レット症候群 [臨床試験数:36,薬物数:49(DrugBank:19),標的遺伝子数:77,標的パスウェイ数:112
Searched query = "Rett syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 36 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04304482July 1, 20208/3/2020ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeA Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett SyndromeRett SyndromeDrug: ANAVEX2-73 oral liquid;Drug: Placebo oral liquidAnavex Life Sciences Corp.Anavex Australia Pty Ltd.;Anavex Germany GmbHRecruiting5 Years18 YearsFemale69Phase 2/Phase 3Australia